Inhaled Glucocorticoids Products Return to Non-Preferred Status on September 18, 2020

Inhaled Glucocorticoids Products Return to Non-Preferred Status on September 18, 2020

FirstCare temporarily removed the non-preferred status on April 2 in response to reported drug shortages for medications in the "Glucocorticoids, Inhaled" drug class. FirstCare will reverse this change in status because of sufficient availability in the market. Beginning September 18, 2020 the formulary will reflect the PDL status changes for all non-preferred inhaled glucocorticoid products. For additional information and a list of preferred PDL NDCs please click here

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.